Clinical protocol. A phase II study: efficacy of the gene therapy of the MVA E2 recombinant virus in the treatment of precancerous lesions (NIC I and NIC II) associated with infection of oncogenic human papillomavirus.

Source:http://linkedlifedata.com/resource/pubmed/id/12067445

Hum. Gene Ther. 2002 Jun 10 13 9 1127-40

Download in:

View as

Triples

General Info

PMID
12067445